互动动态头皮针改善脑卒中后下肢运动与步态:多中心随机对照试验
该多中心随机对照试验将231例脑卒中后偏瘫患者随机分为互动动态头皮针组(78例)、简单联合治疗组(78例)和传统头皮针组(75例),治疗8周并随访2个月。结果显示互动动态头皮针在下肢运动功能、平衡、日常生活能力和步行能力方面优于简单联合治疗和传统头皮针,简单联合治疗与传统头皮针相当,且可能在下肢关节活动度改善方面更优。
要点
- 互动动态头皮针可显著改善脑卒中后下肢运动功能、平衡和步行能力。
- 疗效优于简单联合治疗和传统头皮针,且效果持续至随访2个月。
- 简单联合治疗与传统头皮针总体相当,可能更利于下肢关节活动度。
核心结论
- 互动动态头皮针对脑卒中后下肢运动功能和步行能力的疗效优于简单联合治疗和传统头皮针。
- 简单联合治疗与传统头皮针疗效相当,且可能在下肢关节活动度改善方面更优。
研究设计与样本
- 多中心随机对照临床试验,共纳入231例脑卒中后偏瘫患者,随机分为互动动态头皮针组78例、简单联合治疗组78例和传统头皮针组75例。
- 互动动态头皮针组和简单联合治疗组均接受头皮针和下肢机器人训练,传统头皮针组仅接受头皮针而不接受下肢机器人训练。
- 治疗每日1次、每周6次、连续8周,每次30分钟;于治疗前、治疗1个月和2个月以及随访1个月和2个月时评估。
主要发现
- 治疗8周及随访2个月时,互动动态头皮针组FMA-LE、BBS、6MWT和MBI评分较简单联合治疗组和传统头皮针组显著提高(P<0.05或P<0.01)。
- 治疗8周时,互动动态头皮针组SF、PROM-H、PROM-K和PROM-A较简单联合治疗组和传统头皮针组显著增加(P<0.05或P<0.01)。
- 治疗8周时,互动动态头皮针组ASFA较简单联合治疗组显著降低(P<0.05)。
- 随访1个月时,互动动态头皮针组ASFA较简单联合治疗组显著降低,随访2个月时SF、SL、PROM-K和PROM-A显著增加(P<0.05或P<0.01)。
- 治疗8周时简单联合治疗组SF较传统头皮针组显著增加,随访2个月时PROM-K和PROM-A显著增加(P<0.05)。
临床怎么用
- 对脑卒中后偏瘫下肢运动功能障碍患者,可考虑采用互动动态头皮针联合下肢机器人训练以改善运动功能、平衡和步行能力。
- 互动动态头皮针疗效可能优于单纯头皮针或简单联合治疗,且效果可维持至治疗后2个月随访。
局限性
- 共有19例患者退出试验(互动动态头皮针组8例、简单联合治疗组5例、传统头皮针组6例),可能影响结果解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effects of interactive dynamic scalp acupuncture (IDSA), simple combination therapy (SCT), and traditional scalp acupuncture (TSA) on motor function and gait of the lower limbs in post-stroke hemiplegia patients. METHODS: A total of 231 patients with post-stroke hemiplegia was randomly divided into IDSA (78 cases), SCT (78 cases), and TSA (75 cases) groups by a random number table. Scalp acupuncture (SA) and lower-limb robot training (LLRT) were both performed in the IDSA and SCT groups. The patients in the TSA group underwent SA and did not receive LLRT. The treatment was administered once daily and 6 times weekly for 8 continuous weeks, each session lasted for 30 min. The primary outcome measures included Fugl-Meyer assessment of the lower extremity (FMA-LE), berg balance scale (BBS), modified barthel index (MBI), and 6-min walking test (6MWT). The secondary outcome measures included stride frequency (SF), stride length (SL), stride width (SW), affected side foot angle (ASFA), passive range of motion (PROM) of the affected hip (PROM-H), knee (PROM-K) and ankle (PROM-A) joints. The patients were evaluated before treatment, at 1- and 2-month treatment, and 1-, and 2-month follow-up visits, respectively. Adverse events during 2-month treatment were observed. RESULTS: Nineteen patients withdrew from the trial, with 8 in the IDSA and 5 in the SCT groups, 6 in the TSA group. The FMA-LE, BBS, 6MWT and MBI scores in the IDSA group were significantly increased after 8-week treatment and 2 follow-up visits compared with the SCT and TSA groups (P<0.05 or P<0.01). Compared with pre-treatment, the grade distribution of BBS and MBI scores in the 3 groups were significantly improved at 1, 2-month treatment and 2 follow-up visits (P<0.05 or P<0.01). The SF, PROM-H, PROM-K and PROM-A in the IDSA group was significantly increased compared with the SCT and TSA groups after 8-week of treatment (P<0.05 or P<0.01). Compared with the SCT group, ASFA of the IDSA group was significantly reduced after 8-week of treatment (P<0.05). SF, SL, PROM-K and PROM-A were significantly increased at the 2nd follow-up visit whereas the ASFA was significantly reduced in the IDSA group compared with the SCT groups at 1st follow-up visit (P<0.05 or P<0.01). The SF was significantly increased in the SCT group compared with the TSA group after 8-week treatment (P<0.05). Compared with the TSA group, PROM-K, PROM-A were significantly increased at the 2nd follow-up visit (P<0.05). CONCLUSIONS: The effects of IDSA on lower-limb motor function and walking ability of post-stroke patients were superior to SCT and TSA. The SCT was comparable to TSA treatment, and appeared to be superior in improving the motion range of the lower extremities. (Registration No. ChiCTR1900027206).
引用
- Zhang SH, Wang YL, Zhang CX, et al. Effects of Interactive Dynamic Scalp Acupuncture on Motor Function and Gait of Lower Limbs after Stroke: A Multicenter, Randomized, Controlled Clinical Trial. Chin J Integr Med. 2021. PMID: 34913147. doi:10.1007/s11655-021-3525-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。